Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

MLA

Caroline L. Behr, et al. “Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-Risk Medicare Beneficiaries, 2020-2021.” JAMA, vol. 327, no. 10, Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....360b344c46aa6933cab255fe942f8d2f&authtype=sso&custid=ns315887.

APA

Caroline L. Behr, Karen E. Joynt Maddox, Ellen Meara, Arnold M. Epstein, E. John Orav, & Michael L. Barnett. (2022). Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021. JAMA, 327(10).

Chicago

Caroline L. Behr, Karen E. Joynt Maddox, Ellen Meara, Arnold M. Epstein, E. John Orav, and Michael L. Barnett. 2022. “Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-Risk Medicare Beneficiaries, 2020-2021.” JAMA 327 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....360b344c46aa6933cab255fe942f8d2f&authtype=sso&custid=ns315887.